No results for ‘’
Novartis India Ltd
₹2046.80
(1.70%)
Thu, 24 Sept 2026, 08:34 pm
Health Technology
Pharmaceuticals: Major
24.5KNovartis India Price to Cash Flow Ratio
No Result Found
| Particulars |
|---|
| No Result Found |
Novartis India Ltd Price to Cash Flow Ratio
The Novartis India Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Novartis India Ltd's valuation, profitability, and overall financial performance. Tracking the Novartis India Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Novartis India Ltd (NSE: NOVARTIND, BSE: 500672) is currently trading at ₹2046.80, with a market capitalization of ₹5137.78Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Novartis India Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Novartis India Ltd Price to Cash Flow Ratio Current Value
The current Novartis India Ltd Price to Cash Flow Ratio stands at 0.
The Novartis India Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.
Novartis India Ltd Price to Cash Flow Ratio Historical Trend
The Novartis India Ltd Price to Cash Flow Ratio has shown the following historical trend:
The decline in Novartis India Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Novartis India Ltd Price to Cash Flow Ratio Indicates for Investors
The Novartis India Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Novartis India Ltd Price to Cash Flow Ratio Analysis Summary
The Novartis India Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Novartis India Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Novartis India Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.